AtriCure ATRC Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax by Product | |||||
| Appendage management | $220.18M+18.6% | $185.66M+16.0% | $160.02M+20.9% | $132.38M+20.2% | |
| Minimally invasive ablation | $39.85M-26.0% | $53.84M+5.1% | $51.25M+15.1% | $44.54M-2.7% | |
| Open ablation | $184.89M+16.8% | $158.34M+15.8% | $136.77M+21.1% | $112.93M+18.1% | |
| Pain management | $89.62M+32.8% | $67.47M+31.7% | $51.21M+26.3% | $40.53M+77.4% | |
| Revenue from Contract with Customer, Excluding Assessed Tax by Geography | |||||
| Europe | $61.49M+23.3% | $49.87M+29.6% | $38.47M+26.4% | $30.43M+8.9% | |
| Other International | $6.94M+32.5% | $5.24M+93.6% | $2.71M+34.2% | $2.02M+69.4% | |
| Total International | $99.16M+20.2% | $82.49M+25.6% | $65.7M+23.5% | $53.18M+17.7% | |
| United States | $435.37M+13.7% | $382.82M+14.8% | $333.54M+20.3% | $277.2M+21.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AtriCure break its business down?
- AtriCure (ATRC) reports revenue from contract with customer, excluding assessed tax by product across 4 parts — Appendage management, Minimally invasive ablation, Open ablation and Pain management. Each is extracted from the segment footnotes and tracked over time.
- Where does AtriCure's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AtriCure's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
